πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

448 results for β€œRAD” Clear

  1. Radiolabeled Prucalopride Succinate

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  2. Radiolabeled SPD557

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  3. Radiolabeled SPD602 (FBS0701, SSP-004184)

    Takeda

    Healthy

    phase 1 small molecule completed

    1 trial

  4. Radiolabelled Diclofenac Tablet A

    BRIGHT MINDS BIOSCIENCES INC.

    Pain

    phase 1 small molecule completed

    1 trial

  5. Radiolabelled T4 Tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Pain

    phase 1 small molecule completed

    1 trial

  6. Recombinant Humanized Anti-IL-36R Monoclonal antibody and Placebo

    Shanghai University of Traditional Chinese Medicine

    Healthy

    phase 1 small molecule completed

    1 trial

  7. Recombinant oncolytic herpes simplex virus type β…  (R130)

    Shanghai University of Traditional Chinese Medicine

    Osteosarcoma

    phase 1 small molecule active

    1 trial

  8. Regorafenib in combination with temozolomide with or without radiotherapy in patients with newly diagnosed MGMT-Methylated, IDH wild-type glioblastoma. A phase I dose-finding study (REGOMA-2).

    Istituto Gentili S.r.l.

    MGMT-Methylated, IDH wild-type glioblastoma

    phase 1 other active

    1 trial

  9. SAR447971 first-in-human study

    Sanofi-aventis Healthcare Pty Ltd

    Hidradenitis

    phase 1 other active

    1 trial

  10. SCT-001 CAR-T cells

    Shanghai University of Traditional Chinese Medicine

    Ovarian Cancer

    phase 1 mab active

    1 trial

  11. SYHA1813 oral solution (2.0g:25mg)

    Shanghai University of Traditional Chinese Medicine

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  12. Sativex(Registered Trademark)

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis

    phase 1 small molecule completed

    1 trial

  13. Segesterone Acetate and Ethinyl Estradiol

    TherapeuticsMD

    Contraception

    phase 1 small molecule completed

    1 trial

  14. Segesterone Acetate and Ethinyl Estradiol

    TherapeuticsMD

    Women

    phase 1 small molecule completed

    1 trial

  15. Single microdose trial - CXCR4 PET tracer - Pharmacokinetics and pharmacodynamics of [68Ga]Ga-R54, a CXCR4-targeted radiopharmaceutical in patients with advanced solid tumors.

    Fondazione Telethon ETS

    Advanced solid neoplasm (breast, lung, colon, ovary, pancreas) characterized by positive CXCR4 expression by immunohistochemistry

    phase 1 other active

    1 trial

  16. Single-Ascending Doses of 2-Methoxyestradiol in Healthy Non-Pregnant Female Subjects.

    Laboratorios Tillomed Spain S.L.U

    No medical condition.

    phase 1 other active

    1 trial

  17. Study to evaluate the addition of an experimental drug, CC-90010, to the usual treatment of brain cancer after surgery

    Celgene Europe Limited

    Subjects with newly diagnosed WHO Grade IV glioblastoma (ndGBM) who have undergone complete or partial tumor resection

    phase 1 other active

    1 trial

  18. TQB2825 Injection (Subcutaneous Injection)

    Shanghai University of Traditional Chinese Medicine

    CD20-positive Hematological Malignancies

    phase 1 small molecule active

    1 trial

  19. Talampanel (non-radiolabeled), [14C] Talampanel

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule terminated

    1 trial

  20. Tetrahydrobiopterin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Radiation-Induced Dermatitis

    phase 1 small molecule active

    1 trial

  21. Trial of the novel peroral anti-tumor treatment in patients with solid tumors

    Lacuna Pharma Pty Ltd

    Metastatic or locally advanced solid tumors for which no standard therapy exists or standard therapy has failed: tumors of lung, head and neck, colon, stomach, esophagus, breast, ovary and/or fallopian tube or primary peritoneal high-grade serous carcinoma

    phase 1 other active

    1 trial

  22. YZJ-1139 tablets

    Shanghai University of Traditional Chinese Medicine

    Insomnia

    phase 1 small molecule active

    1 trial

  23. [203Pb]VMT-Ξ±-NET

    Perspective Therapeutics

    Neuroendocrine Tumor Grade 2

    phase 1 small molecule active

    1 trial

  24. radioactive substance

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    phase 1 other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources